While antibiotics have treated most Urinary Tract Infections (UTIs) over the past, resistance to these medications has been expanding. About 20% of infected people are reportedly resistant to UTI antibiotics.
This is an unfortunate trend, as complicated UTIs may lead to hospitalized florid urosepsis, which can be fatal.
According to recent news, innovative UTI treatments are accelerating in clinical trials and gaining regulatory approvals to meet the needs of millions of women and men impacted by this common infectious disease.
Advanced UTI Treatments Becoming Available
Widening Disparities Seen in Youth Obesity
Despite improvements overall, increases in obesity and severe obesity seen for Black and Hispanic students in most recent years
Two Countries Defeat Wild Poliovirus Transmission
Amongst the 34 countries reporting polio cases in 2024, two African countries confirmed today the closure of the wild poliovirus type 1 (WPV1) outbreak, marking a significant milestone in the fight against polio in the African region.
On May 14, 2024, following thorough assessments in Malawi and Mozambique, an independent Polio Outbreak Response Assessment Team recommended the closure of these WPV1 outbreaks.
100 Million African Children Receiving Measles and Rubella Vaccines
Gavi, the Vaccine Alliance, is collaborating with partners in Africa to reach up to 100 million children with measles and rubella vaccines in 2024.
Are Ebola Vaccine Boosters Needed Now
With an ample supply of World Health Organization-approved Zaire ebolavirus (EBOV) vaccines and antibody therapies available in 2024, a group of scientists recently presented a strategy to pre-empt the next outbreak.
Ebolaviruses were first described in 1976 in the Democratic Republic of the Congo. Since then, ebola outbreaks have emerged periodically in several African countries.
The last Ebola outbreak was recorded in Uganda in 2022, resulting in 164 confirmed cases, including 55 deaths.
High Telehealth Use Tied to Increased Health Care Utilization, Cost
Areas of high telehealth use also had more ambulatory care-sensitive hospitalizations
Dengue Cases Increase 206% in the Americas
Since 1635, when the first suspected dengue-like epidemics were reported, the World Health Organization (WHO) has stated that dengue has become endemic in about 125 countries.
Unfortunately, dengue outbreaks have continued in various regions in 2024.
On May 10, 2024, the Pan American Health Organization (PAHO) published Situation Report No. 16, confirming that 6,769,140 suspected cases of dengue and 1,733 deaths were registered in 2024.
$2.1 Billion Agreement Accelerates Immunotherapies Targeting Toxic Forms of Amyloid Beta
A potential first-in-class active immunotherapy designed to delay or slow Alzheimer's disease progression may realize up to approximately $2.1 billion in new funding.
Takeda and AC Immune SA today announced an exclusive, worldwide option and license agreement for AC Immune's active immunotherapies, including ACI-24.060, which targets toxic forms of amyloid beta (Abeta).
Some Children Prescribed Nonrecommended Meds for COVID-19
Some children were prescribed ineffective and potentially harmful medications for acute COVID-19
$1.4 Billion Transaction Leverages Matrix-M Adjuvant Vaccine Technology
An international agreement that may reach $1.4 billion in value may disrupt the COVID-19 and influenza vaccine industry.
As part of Sanofi's commitment to developing a diverse portfolio of best-in-class vaccines, the company announced today it has entered into a co-exclusive licensing agreement with Novavax Inc., a global leader in protein-based, non-mRNA, adjuvanted COVID-19 vaccines.